Rafal Sadej

Medical University of Gdansk

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Tissue Engineering Tissue Engineering professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (12)

Adrianna Cieślak

Medical University of Lodz

POLAND

View details

Katarzyna Lisowska

Associate Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Dominika Piasecka

Medical University of Gdansk

POLAND

View details

Adam Jacek Krętowski

Medical University of Bialystok

POLAND

View details

Hanna Romanska-Knight

assistant professor

Medical University of Lodz

POLAND

View details

Katarzyna Kujawa

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Anna J Zaczek

professor/head

Medical University of Gdansk

POLAND

View details

Adrianna Skwira-Rucińska

Assistant Professor

Medical University of Gdansk

POLAND

View details

Magdalena Prokopowicz

Prof.

Medical University of Gdansk

POLAND

View details

Adrian Szczepaniak

Mossakowski Medical Research Institute, Polish Academy of Sciences

POLAND

View details

Adrian Szewczyk

Assistant Professor, PharmD

Medical University of Gdansk

POLAND

View details

Magdalena Niemira

Assistant Professor

Medical University of Bialystok

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rafal Sadej

Research Interests

Explore related searches

Contact this professor

Articles (16)

Biocompatible antibiotic-loaded mesoporous silica/bioglass/collagen-based scaffolds as bone drug delivery systems

Bioglass obtained via one-pot synthesis as osseointegrative drug delivery system

FGFR2 Controls Growth, Adhesion and Migration of Nontumorigenic Human Mammary Epithelial Cells by Regulation of Integrin β1 Degradation

ERα36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer

Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2

FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer

p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer

Mesoporous Silica-Bioglass Composite Pellets as Bone Drug Delivery System with Mineralization Potential

MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells.

Simplified theta-defensin [ser3,7,12,16] rtd-2 analog is involved in proteasomal degradation pathway in breast cancer

Mesoporous silica pellets as bifunctional bone drug delivery system for cefazolin

Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli.

Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma

A ‘Real-Life’ Experience on Automated Digital Image Analysis of FGFR2 Immunohistochemistry in Breast Cancer

Biphasic composite of calcium phosphate-based mesoporous silica as a novel bone drug delivery system

Silica-polymer composites as the novel antibiotic delivery systems for bone tissue infection

Collaborators (12)

Adrianna Cieślak

Katarzyna Lisowska

Dominika Piasecka

Adam Jacek Krętowski

Hanna Romanska-Knight

Katarzyna Kujawa

Anna J Zaczek

Adrianna Skwira-Rucińska

Magdalena Prokopowicz

Adrian Szczepaniak

Adrian Szewczyk

Magdalena Niemira

Make your next move.

Rafal Sadej

Research Interests

Explore related searches

Contact this professor

Articles (16)

Biocompatible antibiotic-loaded mesoporous silica/bioglass/collagen-based scaffolds as bone drug delivery systems

Bioglass obtained via one-pot synthesis as osseointegrative drug delivery system

FGFR2 Controls Growth, Adhesion and Migration of Nontumorigenic Human Mammary Epithelial Cells by Regulation of Integrin β1 Degradation

ER&alpha;36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer

Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2

FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer

p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer

Mesoporous Silica-Bioglass Composite Pellets as Bone Drug Delivery System with Mineralization Potential

MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells.

Simplified theta-defensin [ser3,7,12,16] rtd-2 analog is involved in proteasomal degradation pathway in breast cancer

Mesoporous silica pellets as bifunctional bone drug delivery system for cefazolin

Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli.

Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma

A ‘Real-Life’ Experience on Automated Digital Image Analysis of FGFR2 Immunohistochemistry in Breast Cancer

Biphasic composite of calcium phosphate-based mesoporous silica as a novel bone drug delivery system

Silica-polymer composites as the novel antibiotic delivery systems for bone tissue infection

Collaborators (12)

Adrianna Cieślak

Katarzyna Lisowska

Dominika Piasecka

Adam Jacek Krętowski

Hanna Romanska-Knight

Katarzyna Kujawa

Anna J Zaczek

Adrianna Skwira-Rucińska

Magdalena Prokopowicz

Adrian Szczepaniak

Adrian Szewczyk

Magdalena Niemira

Make your next move.

ERα36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer